Roche's $1.25B investment in U.S. facilities boosts drug manufacturing and diabetes tech, creating thousands of jobs.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in Holly ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation ...

May 12 (Reuters) - Roche Group (ROG.S), opens new tab said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to ...

About a month after disclosing a $50 billion investment in its U.S. | Roche has earmarked more than $700 million to construct ...

Roche’s Genentech unit has announced a $700 million investment in a new 700,000-square-foot drug manufacturing facility in Holly Springs, NC. According to the company, the site will support its ...

The new site will support Roche and its unit Genentech's future portfolio of next-generation obesity medicines.

Roche and Genentech to spend $700 million building new manufacturing facility May 12, 2025 by Mai Tao Genentech , a ...

facility in Holly Springs ... and advance cutting-edge scientific innovation right here in North Carolina.” Together, Roche and Genentech are advocating for a vibrant biotech community and ...